Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
Phase 3
Recruiting
- Conditions
- Chronic Traumatic EncephalopathyAlzheimer Disease
- Interventions
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- CereMark Pharma, LLC
- Target Recruit Count
- 230
- Registration Number
- NCT06254469
- Locations
- 🇺🇸
Endeavor Health Systems, Evanston, Illinois, United States
News
No news found